Business Wire

UNIVERSAL-LASER-SYSTEMS

Share
Universal Laser Systems Installs the First High-Power Multiwave HybridTM System at the Mittelhessen University of Applied Sciences in Friedberg, Germany

Universal Laser Systems, Inc., the world’s leader in equipment for laser material processing, has installed a High-Power XLS10MWH laser system with the patented Multiwave HybridTM technology in the newly opened applied optics laboratory facilities of the University of Applied Sciences in Friedberg, Germany. Equipped with a 250W CO2 laser and a 50W fiber laser, this advanced system represents top-of-the-line laser material processing technology, and will greatly expand the testing and research capabilities of the faculty and students in the Department of Applied Physics at the Mittelhessen University of Applied Sciences in the area of hybrid technology.

The Department of Physical Engineering at the Mittelhessen University of Applied Sciences, which is an integral part of the Applied Physics Department, recently celebrated its 20th anniversary, and a significant event in this milestone was the ceremonial opening of a modern laboratory facility in a newly incorporated part of the university campus. This new building provides students and faculty members with spacious seminar, office and lecture facilities, as well as a host of modern machines, equipment, and laboratory space for research projects and practical lab work. With an emphasis on applied optics and laser technology, the Department of Physical Engineering is tightly linked to important suppliers of laser technology and can boast many years of experience in the use of high-tech laser devices. The new High-Power XLS10MWH system will occupy an important place in both the research and the educational activities of the department, and will render possible the processing and testing of materials, including plastic films, industrial films, engineering plastics, laminating adhesives and composite materials, as well as many others.

“With this system, we see excellent possibilities for expanding our expertise in the processing and testing of complex composite materials, and look forward to sharing and exchanging these findings with relevant companies in the surrounding area,” says Professor Doctor Klaus Behler, Head of the academic group for Applied Laser Technology at the institute. “In this way, our cooperation with partners in industry will be strengthened for the good of everyone, and our students will be able to gain new insights into material processing that are relevant in industrial applications.” The German university system of Applied Sciences has a clear charter to develop strong relationships with industrial companies, which is meant to provide students practical experience and get them involved in projects that are relevant to these potential employers in their region. The Mittelhessen University of Applied Sciences is located in one of the most technologically advanced regions in Germany and profits immensely from its interactions with local industrial players.

Daniel Thölken, a master’s graduate of the Mittelhessen University of Applied Sciences, was the primary driver behind the acquisition of the XLS-System. He manages the many high-tech devices in the newly equipped laboratory facility and said the following with respect to the recently installed machine from ULS: “We are very much looking forward to testing the extensive capabilities of this technology. Whether using the high-power 250W laser alone or in conjunction with the fiber laser, we will be able to undertake sophisticated tests on myriad different materials. In this process, we are especially hopeful that we will be able to discover new applications for the Multiwave Hybrid technology.”

The industry-first Multiwave Hybrid laser system combines beams from multiple lasers into a single, hybrid laser beam. Users can leverage this technology to combine a number of different laser power levels and wavelengths. For example, 1.06 µm, 9.3 µm and 10.6 µm laser beams can be combined in any proportion to create a number of desired effects on various materials. Additionally, users can independently control each laser.

Kevin Kearney, Managing Director for EMEA at Universal Laser Systems, sees great potential in cooperating with the Mittelhessen University of Applied Sciences: “The combination of academic research and proximity to industry at the Mittelhessen University of Applied Sciences is truly unique. We are convinced that the cooperation will be beneficial for all parties, and that the students and faculty at the University of Applied Sciences will discover new and important applications for our Multiwave Hybrid technology.”

About Universal Laser Systems

Universal Laser Systems, Inc. (ULS) is a global manufacturer of laser material processing solutions, founded in 1988 and headquartered in Scottsdale, Arizona, with subsidiaries in Vienna, Austria and Yokohama, Japan. The company’s commitment to innovation, advancing the application of modern CO2 and fiber laser technology, and customer service has established a market-leading position with tens of thousands of customers in various industries across the globe.

From the development of laser sources, productivity enhancement technologies, advanced software and beam delivery systems to an extensive investment in the research of laser materials processing science and applications, ULS is committed to providing its customers with the most innovative, cost effective, flexible and scalable laser material processing solutions for today and future needs. For more information visit www.ulsinc.com .

About the Mittelhessen University of Applied Sciences

The Mittelhessen University of Applied Sciences is a German institution of higher learning with locations in FriedbergGießen  and Wetzlar , as well as branch campuses in Bad HersfeldBad WildungenBad VilbelBiedenkopf  and Frankenberg . The university was established in 1971 and is accordingly one of the newest institutions of its kind in the federal state of Hessen. With 17,227 students (2016), it is the largest of the five universities of applied sciences in the federal state of Hessen. On a national basis, the Mittelhessen University of Applied Sciences is the fourth largest behind similar institutions in Cologne, Munich and Hamburg. www.thm.de .

Contact:

Universal Laser Systems, Inc.
Mark Schaefer, 480-483-1214 x 298
Senior Marketing Manager
mschaefer@ulsinc.com
www.ulsinc.com

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

ImmunAbs Announces FDA Phase 2 IND Approval of IM-101, a Novel Complement C5 Inhibitor, for Treatment of Myasthenia Gravis2.6.2025 13:00:00 CEST | Press release

ImmunAbs Inc., a clinical-stage biotech specializing in developing antibody therapeutics, today announced that the U.S. Food and Drug Administration has cleared its Investigational New Drug (IND) application to initiate a Phase 2 clinical trial evaluating the safety and efficacy of IM-101, a novel complement C5 inhibitor, for the treatment of Myasthenia Gravis. The forthcoming multicenter, randomized, double-blind, placebo-controlled study will enroll up to 90 patients to evaluate the effectiveness and safety of monthly IM-101 dosing in relieving complement-induced symptoms in MG. “This IND approval is pivotal for us as it brings us one step closer to delivering a transformative therapy for patients with autoimmune disorders”, said Dr. Dongjo Kim, the CEO of ImmunAbs, “we believe IM-101 has the potential to deliver deeper therapeutic responses and more durable remissions in patients who have failed to achieve sustained remission with current approved treatment.” About Myasthenia Gravis

Lenovo and Bellevue University Team Up to Offer Supply Chain and Logistics Education to Deliver “Smarter Technology for All”2.6.2025 13:00:00 CEST | Press release

Learners will have access to Lenovo’s globally recognized supply chain expertise through real-world case studies and subject matter experts. Lenovo, the global technology powerhouse, recognized in the top 10 in the Gartner Supply Chain Top 25, and Bellevue University, one of the nation’s top online universities, are teaming up to develop the next generation of supply chain professionals. “We believe that bringing real-world Global Supply Chain experience and learning directly into an education curriculum is precisely the optimal way to upskill the workforce of the future,” said Ben Massie, Vice President, Global Supply Chain, Lenovo. “Teaming up with Bellevue allows us to attract the right talent using the right technology and deliver on our mission to make ‘smarter technology for all’ a reality.” As a preferred higher education institution tapped to team up with Lenovo to offer supply chain short-term learning, Bellevue will leverage the breadth and depth of Lenovo’s supply chain expe

Lifezone Metals Files Initial Assessment for the Kabanga Nickel Project in Tanzania2.6.2025 12:30:00 CEST | Press release

Vertically Integrated Plan includes Hydrometallurgical Refinery at Kahama $2.37 Billion After-Tax NPV (8%) and 22.9% After-Tax IRR at $8.49 per Pound Nickel Price Initial Assessment Proposes a 22-Year Mine Plan at Average 2.39% Nickel Equivalent Grade Webcast with Technical Leadership Team at 10 AM ET on Tuesday, June 3, 2025 Lifezone Metals Limited’s (NYSE: LZM) Chief Executive Officer, Chris Showalter, and Chief Operating Officer, Gerick Mouton, announce today the results from the Initial Assessment for its flagship Kabanga Nickel Project in northwest Tanzania. The Initial Assessment evaluates a vertically integrated mining, processing and refining operation, commencing with a high-grade nickel sulfide underground mine and concentrator at the Kabanga site, followed five years later by a hydrometallurgical refinery at Kahama. The study covers the Main, MNB, Kima, North, and Tembo zones and is based on the December 2024 Mineral Resource Update (refer to Lifezone’s December 5, 2024 news

Corpay Cross-Border Named an Official Partner of Real Madrid C.F.2.6.2025 12:00:00 CEST | Press release

Providing access to currency risk management and cross-border payments solutions Corpay, Inc.*, (NYSE: CPAY) a global leader in corporate payments, is pleased to announce that Corpay’s Cross-Border business has entered into an agreement with Real Madrid C.F. to become an Official Partner. Through this partnership, Real Madrid will be able to gain access to and utilise Corpay Cross Border’s innovative solutions to help mitigate foreign exchange exposure from their day-to-day business needs. "The Corpay Cross-Border team is elated to be named an Official Partner of Real Madrid, one of the world’s most widely recognized and followed sports franchises," said Brad Loder, Chief Marketing Officer, Corpay Cross-Border Solutions. “With our strong focus on growing the Corpay brand, as well as our currency risk management business, we are excited to partner with one of the most successful football clubs in the world.” About Corpay Corpay, Inc. (NYSE: CPAY) is a global S&P500 corporate payments co

BeOne Medicines Unveils Promising Clinical Data for Two Novel Breast Cancer Therapies at ASCO 20252.6.2025 12:00:00 CEST | Press release

Preliminary results highlight anti-tumor activity and favorable safety profiles of both B7-H4-targeting ADC and CDK2 inhibitorData underscore strength of emerging breast cancer pipeline as part of BeOne’s global transformation with next wave of innovation BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, announced new clinical data from its emerging breast cancer pipeline at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. Poster presentations feature preliminary results of the dose escalation studies of two investigational molecules: BG-C9074, a novel B7-H4-targeting antibody-drug conjugate (ADC) in patients with advanced solid tumors, including breast cancer, and BG-68501, a cyclin-dependent kinase-2 inhibitor (CDK2i), in HR+/HER2- breast cancer patients with prior CDK4/6i exposure. “Presenting the first clinical data for two novel breast cancer candidates at ASCO 2025 marks a pivotal moment for BeOne,” said Mark Lanas

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye